Your Search Results

Valvular and structural interventions

16 May 2024 – From EuroPCR 2024

This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

TEER for primary mitral regurgitation - LIVE case

15 May 2024 – From EuroPCR 2024

A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...

Asymptomatic severe aortic stenosis: Will these trials change my practice?

16 May 2024 – From EuroPCR 2024

This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...

Antegrade CTO - LIVE case

16 May 2024 – From EuroPCR 2024

This session features a LIVE educational case from Netcare Sunninghill Hospital in Johannesburg, South Africa, focusing on the management of chronic total occlusions (CTOs) using an antegrade approach. Participants will learn how to identify CTO anatomy through dual injection, as well as how to perform IVUS-guided...

Upgrade to retrograde: when and how?

16 May 2024 – From EuroPCR 2024

This session delves into the decision-making for transitioning to a retrograde approach in CTO PCI, covering effective techniques and safety considerations for successful outcomes, through cases involving antegradely induced hematomas and ambiguous CTO caps, alongside severe distal atherosclerosis.

TAVI - Step by step

16 May 2024 – From EuroPCR 2024

This interactive session provides a step-by-step guide on performing minimalist TAVI procedures. Attendees will learn how to optimize TAVI for speed and safety, with a deep dive on the safest techniques for large-bore arterial access and vessel closure. Key topics include femoral access, fluoroscopic projections, crossing...

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

16 May 2024 – From EuroPCR 2024

This session presents the first results of randomized trials investigating the use of advanced plaque modification techniques, such as rotational atherectomy, lithotripsy, and laser atherectomy, as well as the role of intracoronary imaging (OCT and IVUS) in guiding percutaneous coronary intervention (PCI). The session aims to...

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

TAVI: procedural complications - Part 1

17 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on the management of various procedural complications that can arise during Transcatheter Aortic Valve Implantation (TAVI). Participants will delve into cases involving unexpected outcomes, such as nosecone-related issues, dysphagia and haematemesis, and frozen leaflets in self-expanding...

Navigating TAVI Complications: Strategies for Success

Role of PCI in the contemporary management of patients with angina and coronary disease

17 May 2024 – From EuroPCR 2024

This session aims to generate awareness about the distinct phenotypes of coronary artery disease (focal, diffuse, serial) that can be identified through contemporary physiological tools, and the implications of these phenotypes on achieving successful functional PCI results. Participants will also discuss the considerations around using PCI...

Role of PCI in the contemporary management of patients with angina and coronary disease

Acute coronary syndromes: keep an eye open for unusual presentations

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 clinical case submissions highlighting unusual presentations of acute coronary syndromes. Cases cover topics such as a "ring" completing the "crown", recurrent vasospastic angina culminating in STEMI, myocardial infarction of unusual cause, and primary PCI in dextrocardia. Discussions emphasize the importance...

Acute coronary syndromes: keep an eye open for unusual presentations

TAVI: how to prevent stroke

17 May 2024 – From EuroPCR 2024

This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.